4//SEC Filing
Rajah Vignesh 4
Accession 0001104659-24-031942
CIK 0001722964other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 5:02 PM ET
Size
6.7 KB
Accession
0001104659-24-031942
Insider Transaction Report
Form 4
Rajah Vignesh
SVP and CMO
Transactions
- Sale
Common Stock
2024-03-05$16.53/sh−1,711$28,283→ 33,889 total
Holdings
- 4,266(indirect: By Spouse)
Common Stock
Footnotes (4)
- [F1]Nondiscretionary sale to cover tax liability associated with the vesting and settlement of restricted stock units.
- [F2]This transaction was executed in multiple trades at prices ranging from $16.52 to $16.555, inclusive. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]Includes 4,033 shares of common stock owned by Reporting Person's spouse and 233 held by Reporting Person's minor child. Reporting Person may be deemed to have a pecuniary interest in the securities due to family relationship.
- [F4]Reporting Person disclaims beneficial ownership of the securities reported and this report shall not be deemed an admission that Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act, as amended, or for any other purpose.
Documents
Issuer
Y-mAbs Therapeutics, Inc.
CIK 0001722964
Entity typeother
Related Parties
1- filerCIK 0001815042
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 5:02 PM ET
- Size
- 6.7 KB